Endocrinology & Diabetes ResearchISSN: 2470-7570

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Bernard P Hughes Author

Subjects of specialization
working in Centre for Cancer Biology, Australia,Cancer Biology

Affiliation
University of South Australia, School of Pharmacy and Medical Sciences, North Terrace, Adelaide, South Australia, 5000, Australia

Biography

Centre for Cancer Biology, University of South Australia and SA Pathology, Frome Road, Adelaide, SA 5000, Australia University of South Australia, School of Pharmacy and Medical Sciences, North Terrace, Adelaide, South Australia, 5000, Australia


Publications

Editorial Subscription

Tryptophan Metabolism- Indoleamine 2,3-Dioxygenase- Friend and Foe

Author(s):

Nesrine Kamal Bassal, Bernard P Hughes and Maurizio Costabile

Tryptophan Metabolism- Indoleamine 2,3-Dioxygenase- Friend and Foe

Indoleamine 2,3-dioxygenase (IDO) (EC 1.13.11.42) is a cytoplasmic, heme-containing enzyme that mediates the initial and rate-limiting step in the oxidative catabolism of the essential amino acid L-tryptophan (L-Trp). Recently, an additional IDO molecule, termed IDO2 has been identified. The gene encoding IDO2 is adjacent to the IDO gene. The IDO2 protein has a different expression profile to IDO and while it is able to metabolize L-Trp, IDO2 has a much higher Km for this substrate. In addition both enzymes differ in their selectivity for some inhibitors. Degradation of L-Trp via IDO leads to the production of several metabolites, including N-formyl-kynurenine and Kynurenine (Kyn).

... view moreĀ»

DOI: 10.4172/2325-9736.1000e107

Abstract HTML PDF Supplementary File



Social Media


Google Scholars / Researchers Sites

GET THE APP